Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia

NCT02899455 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Hyperlipidemia

Interventions

DRUG: HGP0904
DRUG: HGP0608
DRUG: HGP0816
DRUG: HGP0904 Placebo
DRUG: HGP0816 Placebo

Sponsor

Hanmi Pharmaceutical Company Limited